5 Publications
2009
Cu(II) bis(thiosemicarbazone) radiopharmaceutical binding to serum albumin: further definition of species dependence and associated substituent effects
Basken, Nathan E⋅Basken, Nathan⋅Green, Mark A and Green, Mark
Nuclear Medicine and Biology, vol. 36, (no. 5), pp. 495-504, 2009. | Journal Article
 
Elucidation of the human serum albumin (HSA) binding site for the Cu-PTSM and Cu-ATSM radiopharmaceuticals
Basken, Nathan E⋅Basken, Nathan E⋅Mathias, Carla J⋅Mathias, Carla J⋅Green, Mark A and Green, Mark A
Journal of Pharmaceutical Sciences, vol. 98, (no. 6), pp. 2170-2179, 2009. | Journal Article
1999
Receptor-mediated targeting of 67Ga-deferoxamine-folate to folate-receptor-positive human KB tumor xenografts.
Mathias, C J⋅Wang, S⋅Low, P S⋅Waters, David J and Green, Mark A
Nuclear medicine and biology, vol. 26, (no. 1), pp. 23-5, 1999/Jan. | Journal Article
1998
Indium-111-DTPA-folate as a potential folate-receptor-targeted radiopharmaceutical.
Mathias, C J⋅Wang, S⋅Waters, David J⋅Turek, J J⋅Low, P S and Green, Mark A
Journal of nuclear medicine : official publication, Society of Nuclear Medicine, vol. 39, (no. 9), pp. 1579-85, 1998/Sep. | Journal Article
1997
Mixed bis(thiosemicarbazone) ligands for the preparation of copper radiopharmaceuticals: synthesis and evaluation of tetradentate ligands containing two dissimilar thiosemicarbazone functions.
Lim, J K⋅Mathias, C J and Green, Mark A
Journal of medicinal chemistry, vol. 40, (no. 1), pp. 132-6, 1997/Jan/3. | Journal Article